Loading...

Propidium Iodide Solution

Pricing & Availability
Regulatory Status
RUO
Other Names
PI
Ave. Rating
Submit a Review
Product Citations
publications
See Propidium Iodide spectral data
Cat # Size Price Quantity Check Availability Save
421301 2 mL $54
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Propidium iodide (PI) is a fluorescent dye that binds to DNA. When excited by 488nm laser light, it can be detected with in the PE/Texas Red® channel with a bandpass filter 610/10. It is commonly used in evaluation of cell viability or DNA content in cell cycle analysis by flow cytometry.

Product Details
Technical data sheet

Product Details

Formulation
Phosphate-buffered saline, pH 7.2, containing 0.09% sodium azide.
Concentration
0.5 mg/ml
Storage & Handling
The solution should be stored undiluted between 2°C and 8°C, and protect from light. Caution: This solution contains hazardous material; handle with care.
Application

FC - Quality tested
Recommended Usage

The suggested use of this solution for viability staining is 10 µl per million cells in 0.5 ml/test, and incubate for 15 minutes at 4 °C before analysis. For Cell Cycle analysis, please see our Propidium Iodide Cell Cycle Staining Protocol. Caution: This solution is toxigenic and mutagenic; handle with care.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Propidium Iodide Solution can be used in evaluation of apoptosis, cell viability and cell cycle analysis by flow cytometry.

Application References

(PubMed link indicates BioLegend citation)
  1. Vermes I, et al.1995. J. Immunol. Methods 184:39.
  2. Darzynkiewicz Z, et al. 1992. Cytometry 13(8):795.
  3. Douglas RS, et al. 1995. J. Immunol. Methods 188:219.
  4. Sakimoto I, et al. 2006. Cancer Research 66:2287.PubMed
  5. Liu H, et al. 2012. Int J Biochem Cell Biol. 45:408. PubMed
  6. Juel HB, et al. 2013. PLoS One. 8:64619. PubMed
  7. Ren Q, et al. 2013. PLoS One. 8:74732. PubMed
  8. Zhao W, et al. 2013. Clin Immunol. 149:119. PubMed
  9. Beggs KM, et al. 2014. Toxicol Sci. 137:91. PubMed
  10. Ewald SE, et al. 2014. Infect Immun. 82:460. PubMed
  11. Tsou WI, et al. 2014. J Biol Chem. 289:25750. PubMed
  12. Kong S, et al. 2014. J Immunol. 193:5515. PubMed
Product Citations
  1. Li W, et al. 2019. Aging (Albany NY). 0.99375. PubMed
  2. Liu H, et al. 2012. Int J Biochem Cell Biol. 45:408. PubMed
  3. Ewald S, et al. 2014. Infect Immun . 82:460. PubMed
  4. Guo H, et al. 2016. Sci Rep. 6:37559. PubMed
  5. Smith A, et al. 2017. Sci Rep. 7:41872. PubMed
  6. Chan J, et al. 2017. Oncogene. 10.1038/onc.2017.319. PubMed
  7. Uroda T, et al. 2019. Mol Cell. 75:982. PubMed
  8. Lindqvist B, et al. 2022. PLoS Pathog. 18:e1010555. PubMed
  9. Neumann CKA, et al. 2020. Mol Metab. 34:136. PubMed
  10. Hamel Y, et al. 2021. Cell Rep Med. 2:100370. PubMed
  11. Castellanos CA, et al. 2021. Sci Immunol. 6:eabh0707. PubMed
  12. Leeth C, et al. 2021. Animals (Basel). 11:. PubMed
  13. Chen M, et al. 2021. Cancers (Basel). 13:. PubMed
  14. McNeal AS, et al. 2021. Elife. 10:. PubMed
  15. He Y, et al. 2020. Nat Commun. 11:1996. PubMed
  16. Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed
  17. Yoshioka H, et al. 2021. Front Cell Dev Biol. 9:621045. PubMed
  18. Yang Y, et al. 2021. Metabolism. 123:154863. PubMed
  19. Sun X, et al. 2022. JCI Insight. 7: . PubMed
  20. Coray M, et al. 2022. Int J Mol Sci. 23:. PubMed
  21. Ren Q, et al. 2013. PLoS One. 8:74732. PubMed
  22. Zeng H, et al. 2018. Cancer Cell. 34:56:00. PubMed
  23. Lei W, et al. 2020. Sci Rep. 10:7004. PubMed
  24. Wang Y, et al. 2019. Cell. 179:1144. PubMed
  25. Zhang M, et al. 2017. Oncol Lett. 3.069444444. PubMed
  26. Zhang W, et al. 2021. J Clin Invest. 131:. PubMed
  27. Ambrosi TH, et al. 2021. Elife. 10: . PubMed
  28. Schrier S, et al. 2016. Sci Rep. 6:34942. PubMed
  29. O'Neill K, et al. 2016. Genes Dev. 30: 973-988. PubMed
  30. Sapanidou V, et al. 2015. Theriogenology. . PubMed
  31. Kong S, et al. 2014. J Immunol. 193:5515. PubMed
  32. Chen C, et al. 2019. Cell Rep. 29:4200. PubMed
  33. Liu L, et al. 2019. Cell Prolif. :e12718. PubMed
  34. Zou PA, et al. 2021. Oncol Lett. 22:648. PubMed
  35. Masuda T, et al. 2022. iScience. 25:104781. PubMed
  36. Feng L, et al. 2016. J Cell Sci. 129: 2202 - 2212. PubMed
  37. Lange N, et al. 2016. PLoS One. 11: 0160843. PubMed
  38. Jordan PM, et al. 2020. Cell Rep. 33:108247. PubMed
  39. Liu Y, et al. 2017. Acta Biomater. 10.1016/j.actbio.2017.08.021. PubMed
  40. Reighard SD, et al. 2020. Cell Rep Med. :1. PubMed
  41. Zhang S, et al. 2020. Front Immunol. 1.757638889. PubMed
  42. Xu B, et al. 2016. Leukemia. 10.1038/leu.2016.297. PubMed
  43. Yang M, et al. 2021. Med Sci Monit. 27:e930083. PubMed
  44. Domenis R, et al. 2017. PLoS One. 10.1371/journal.pone.0169932. PubMed
  45. Walter F, et al. 2020. PLoS One. 15:e0239369. PubMed
  46. Liu H, et al. 2020. Cell Death Dis. 0.767361111. PubMed
  47. Li L, et al. 2018. Oncol Lett. 4.184722222. PubMed
  48. Jung E, et al. 2017. J Neurosci. 37:6837. PubMed
  49. Basso-Ricci L, et al. 2017. Cytometry A. 10.1002/cyto.a.23148. PubMed
  50. Matsuda K, et al. 2021. Cell Rep Methods. 1:100122. PubMed
  51. Pang K, et al. 2022. Cell Death Dis. 13:169. PubMed
  52. Tang X, et al. 2021. Transl Cancer Res. 10:2120. PubMed
  53. Zhang X, et al. 2020. Eur J Med Chem. 112186:192. PubMed
  54. Mensen A, et al. 2015. Biol Blood Marrow Transplant. Available online 10 August 2015. PubMed
  55. Zhao W, et al. 2013. Clin Immunol. 149:119. PubMed
  56. Litzenburger UM, et al. 2017. Genome Biol. 18:15. PubMed
  57. Shanahan MT, et al. 2021. Am J Physiol Gastrointest Liver Physiol. 321:G668. PubMed
  58. Wang J, et al. 2022. J Clin Invest. :. PubMed
  59. Trudu M, et al. 2022. Front Oncol. 12:968208. PubMed
  60. Li Y, et al. 2016. Int J Lower Extrem Wounds. 10.1177/1534734616649485. PubMed
  61. Hu D, et al. 2020. Proc Natl Acad Sci U S A. 117:30639. PubMed
  62. Li Q, et al. 2020. Acta Biochim Biophys Sin (Shanghai). 52:1131. PubMed
  63. Moribe F, et al. 2021. PLoS One. 16:e0237554. PubMed
  64. Perl AL, et al. 2019. J Biol Chem. 294:17043. PubMed
  65. Diaz Osterman CJ, et al. 2019. Elife. 8:e47327. PubMed
  66. Hosokawa T, et al. 2017. J Immunol. 10.4049/jimmunol.1700157. PubMed
  67. El-Hafeez A, et al. 2017. Cytotechnology. 10.1007/s10616-017-0124-1. PubMed
  68. Xue G, et al. 2021. Nat Biomed Eng. 5:1306. PubMed
  69. Lasrado N, et al. 2022. iScience. 25:103865. PubMed
  70. L Chang, Y Li, D Kaplan 2016. Sci Rep. 6:36862. PubMed
  71. Tsou W, et al. 2014. J Biol Chem. 289:25750. PubMed
  72. Oubaha M, et al. 2016. Sci Transl Med. 8: 362ra144. PubMed
  73. Polk A, et al. 2016. Clin Cancer Res. 22(24):6118-6128. PubMed
  74. El-Hafeez A, et al. 2017. Cytotechnology. 10.1007/s10616-017-0116-1. PubMed
  75. Xie M, et al. 2017. BMC Cancer . 10.1186/s12885-017-3291-8. PubMed
  76. Pal P, et al. 2021. J Med Chem. 64:14230. PubMed
  77. Hedemann N, et al. 2021. Cancers (Basel). 13:. PubMed
  78. Xie B, et al. 2021. J Immunol. 206:1515. PubMed
  79. Harro CM, et al. 2020. J Clin Invest. . PubMed
  80. Imura Y, et al. 2020. JCI Insight. :5. PubMed
  81. Suzuki S, et al. 2021. STAR Protocols. 2:100683. PubMed
  82. Vickman R, et al. 2016. Mol Cancer Res. 14: 776 - 786. PubMed
  83. Huang K, et al. 2018. Biol Open. 7:bio029470. PubMed
  84. Wang H, et al. 2019. Nat Commun. 4.388194444. PubMed
  85. Matsubara T, et al. 2022. J Exp Med. 219:. PubMed
  86. M H, et al. 2016. Cell Transplant. 25: 811-27. PubMed
  87. Woo MS, et al. 2021. J Exp Med. :218. PubMed
  88. Liu X, et al. 2019. Mol Cancer Ther. 18:706. PubMed
  89. Yang X, et al. 2017. J Control Release. 10.1016/j.jconrel.2017.07.014. PubMed
  90. Viereckl MJ, et al. 2022. Biomolecules. 12:. PubMed
  91. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  92. Hughes K, et al. 2017. Open Bio. 10.1098/rsob.160155. PubMed
  93. Resch U, et al. 2016. MBio. 7: e00207-16. PubMed
  94. Bao W, et al. 2016. Sci Rep. 6:22579. PubMed
  95. Bjørnstad R, et al. 2019. Mol Cancer Ther. 1.14375. PubMed
  96. Ghura H, et al. 2021. Neoplasia. 23:837. PubMed
  97. Beggs K, et al. 2014. Toxicol Sci. 137:91. PubMed
  98. Wang C, et al. 2017. Drug Deliv. 10.1080/10717544.2017.1293195. PubMed
  99. Nilsri N, et al. 2021. Sci Rep. 5255:11. PubMed
  100. He Y, et al. 2020. J Hematol Oncol. 0.607638889. PubMed
  101. Widodo N, et al. 2022. F1000Res. 11:169. PubMed
  102. Tu Z, et al. 2022. Cell Rep. 40:111072. PubMed
  103. Bensberg M, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  104. Siddhartha V, et al. 2017. Artif Cells Nanomed Biotechnol . 10.1080/21691401.2017.1313267. PubMed
  105. Viseshakul N, et al. 2017. Parasitol Res. 10.1007/s00436-017-5589-5. PubMed
  106. Chmielewski M and Abken H 2017. Cell Rep.. 10.1016/j.celrep.2017.11.063. PubMed
  107. Sakimoto I, et al. 2006. Cancer Res. 66:2287. PubMed
  108. Goel S, et al. 2021. Nat Commun. 12:5325. PubMed
  109. Szeto C, et al. 2022. Nat Commun. 13:4951. PubMed
  110. Namas R, et al. 2016. Lupus Sci Med. 3: e000148. PubMed
  111. Chen Y, et al. 2016. J Biol Chem. 291: 13216 - 13228. PubMed
  112. Deng BB, et al. 2020. Cell Biol Int. 44:1890. PubMed
  113. Popa S, et al. 2020. Wellcome Open Res. 0.249305556. PubMed
  114. Vulin M, et al. 2022. Oncogene. :. PubMed
  115. Liu Q, et al. 2016. Cell Death Dis. 1.93125. PubMed
  116. Mahmoudi M, et al. 2016. Sci Rep. 6:26960. PubMed
  117. Juel H, et al. 2013. PLoS One. 8:64619. PubMed

Antigen Details

Biology Area
Cell Biology, Cell Cycle/DNA Replication, Neuroscience
Gene ID
NA

Related FAQs

Why is washing not recommended after the addition 7-AAD or PI addition when assessing viability?

These dyes bind in equilibrium with DNA. Therefore, external dye concentration must be maintained during analysis and the dye should not be washed out.

Go To Top Version: 2    Revision Date: 10/08/2015

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login/Register
Remember me
Forgot your password? Reset Password
Request an Account